Qube Research & Technologies Ltd - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$210,719
-68.1%
16,777
-58.1%
0.00%
-66.7%
Q1 2023$660,101
+3.7%
40,079
-5.9%
0.00%0.0%
Q4 2022$636,474
-36.1%
42,602
-28.4%
0.00%
-57.1%
Q2 2022$996,00059,4840.01%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Casdin Capital, LLC 6,923,574$58,227,2576.44%
Finepoint Capital LP 870,870$7,324,0173.65%
Nextech Invest Ltd. 1,196,409$10,061,8003.05%
MPM BioImpact LLC 1,352,133$11,371,4393.04%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$234,680,7391.93%
EcoR1 Capital, LLC 4,163,824$35,017,7601.18%
Integral Health Asset Management, LLC 800,000$6,728,0000.93%
Alphabet Inc. 1,568,753$13,193,2120.85%
HARBOURVEST PARTNERS LLC 296,402$2,492,7410.85%
Boxer Capital, LLC 1,819,132$15,298,9000.81%
View complete list of RELAY THERAPEUTICS INC shareholders